Fidelity Investments’s Tyra Biosciences TYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$117K Sell
12,202
-1,694,946
-99% -$16.2M ﹤0.01% 3549
2025
Q1
$15.9M Sell
1,707,148
-1,400,822
-45% -$13M ﹤0.01% 1754
2024
Q4
$43.2M Sell
3,107,970
-264,880
-8% -$3.68M ﹤0.01% 1438
2024
Q3
$79.3M Buy
3,372,850
+26,187
+0.8% +$616K ﹤0.01% 1193
2024
Q2
$53.5M Sell
3,346,663
-630,545
-16% -$10.1M ﹤0.01% 1291
2024
Q1
$65.2M Buy
3,977,208
+1,208,512
+44% +$19.8M ﹤0.01% 1216
2023
Q4
$38.3M Sell
2,768,696
-1,130,131
-29% -$15.7M ﹤0.01% 1392
2023
Q3
$53.7M Sell
3,898,827
-218,042
-5% -$3M ﹤0.01% 1216
2023
Q2
$70.1M Buy
4,116,869
+968,882
+31% +$16.5M 0.01% 1141
2023
Q1
$50.6M Sell
3,147,987
-731,136
-19% -$11.7M ﹤0.01% 1260
2022
Q4
$29.5M Sell
3,879,123
-147,178
-4% -$1.12M ﹤0.01% 1467
2022
Q3
$35.4M Buy
4,026,301
+58,211
+1% +$512K ﹤0.01% 1382
2022
Q2
$28.4M Sell
3,968,090
-121,995
-3% -$872K ﹤0.01% 1509
2022
Q1
$43.8M Buy
4,090,085
+621,254
+18% +$6.65M ﹤0.01% 1451
2021
Q4
$48.8M Buy
3,468,831
+1,560,172
+82% +$22M ﹤0.01% 1429
2021
Q3
$33.6M Buy
+1,908,659
New +$33.6M ﹤0.01% 1599